Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Parkinson's Disease
NCT07370532Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoricoxib in Parkinson's disease (PD). Started Jan 2026; status: recruiting.
02
Drugs
etoricoxib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07370532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07370532.